{{Rsnum
|rsid=7305773
|Gene=SOX5
|Chromosome=12
|position=23818252
|Orientation=plus
|GMAF=0.07805
|Gene_s=SOX5
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 3.5 | 21.2 | 75.2
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 17.0 | 83.0
| ASW | 0.0 | 17.5 | 82.5
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 1.0 | 11.9 | 87.1
| LWK | 0.0 | 10.0 | 90.0
| MEX | 0.0 | 10.3 | 89.7
| MKK | 0.0 | 8.3 | 91.7
| TSI | 2.9 | 31.4 | 65.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=22688887
|Title=Insight in glioma susceptibility through an analysis of 6p22.3, 12p13.33-12.1, 17q22-23.2 and 18q23 SNP genotypes in familial and non-familial glioma
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}